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Hb P-Nilotic in association with p<>-thalassemia: 
cis-mutation of a hemoglobin pA chain regulatory 
determinant? 
AHMED ABU-SIN , A. E. FELICE, M. E. GRAVELY, .I B. WILSON, A. L REESE, 
H. LAM, A. MILLE R, and T H. J. HUISMAN 
Khartoum, Sudan, and Augusta , Ga . 
Hb P-Nilotic which is produced by a hybrid of f3 and o genes was found in several 
members of a Sudanese family, three of whom had an associated {3 -thalassemia. 
Chemical analyses confirmed the crossover between positions 22 and 50 of the f3oP chain. 
The Hb P-Nilotic heterozygote had completely normal hematology, but the patients with the 
Hb P-Nilotic-{3 -thalassemia condition had moderately severe clinical and hematological 
abnormalities which were considerably more pronounced than those in the father who had 
a {3-thalassemia heterozygosity. The absolute cellular contents of normal and abnormal 
non-a chains in these subjects and the results of in vitro chain synthesis analyses 
suggested that the thalassemia gene in this family is of the {3° type and that the f3A gene 
which is present in cis to the f3oP gene is incapable of being stimulated when the 
{3°-thalassemia determinant is present in trans. It is proposed that a number of 
recombination events produced a f3oP hybrid gene with duplication of the (3A gene in cis 
as well as a change in an untranscribed strand of DNA which controls the expression of 
() the f3A gene. (J LAB CUN MED 93:973, 1979.) 
Abbreviations: hemoglobin, with notation only (Hb), acid-citrate-dextrose (ACD), 
diethylaminoethyl (DEAE), half-life ( t%), carboxymethyl (CM), white blood cell 
(WBC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) 
The genes direc ting the synthesis of the f3 and 8 chains of human hemoglobin are 
closely linked on chromosome No. 11. ' Abnormal recombination between these two struc-
tural genes caused by a mismatching due to base-sequence similarities can result in the 
formation of hybrid genes. One of these, the 8{3 fusion gene, produces a 8/3 chain found in 
the Lepore hemoglobins. 2 Because homozygotes for this type of hybrid hemoglobin have 
Hb Lepore and Hb F but no Hb A and Hb A2, complete f3 and 8 structural genes must 
certainly be absent. ~ Other crossover products are the hemoglobins Miyada4 and P-
Nilotic5- 7; these "anti-Lepore" hemoglobins contain normal a chains and {38 chains. 
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Table I. Hematological and hemoglobin composition data on several members of 
the family with Hb P-Nilotic and ,B-thalassemia 
Hb PCV RBC MCV MCH 
CaseA Condition (gmldl) (111 ) (10'2/J) (fl ) (pg) 
II-3 A-/3-thal 9.5 0.282 4.34 65 22.0 
II-5 AA" 9.6 0.295 3.20 92 30.3 
III-1 P-{3-thal 8.9 0.274 4.35 63 20.5 
III-2 AP 12.8 0.381 4.36 85 27.7 
Second samplel> 12.6 0.376 4.14 91 30.6 
III-3 A- /3-thal 11 .1 0.345 5.81 59 18.2 
III-5 AA' 10.6 0.322 348 92 30.7 
III-6 AAc 13.1 0.392 4.28 92 30.8 
III-7 AAc 9.9 0.323 4.02 80 24.7 
IV-1 P-{3-thal 9.6 0.300 4.66 63 19.5 
Second sample" 10.3 0.327 4.82 68 21.4 
IV-2 P-{3-thal 7.5 0.231 3.92 58 18.0 
Second sample" 9.2 0.284 4.78 60 19.3 
IV-3 AA' 14.6 0.437 5.08 86 29.1 
IV-7 AP 10.0 0.264 3. 16 84 31.9 
PCV = packed cell volume; RBC = red blood cell; MCHC = mean corpuscular hemoglobin concentration. 
ASee pedigree in Fig. l ; ages are known for 11-3 (90 years). Ill-2 (50 years). Ill-3 (56 years), IV-I (26 years), 
and IV-2 (18 years). 
8 By DEAE-cellulose chromatography; %A includes minor A, components. 
'These persons without a hemoglobinopathy are included to serve as internal controls; three of them, all fe-
male over 40 years of age, had a slight anemia probably of nutritional origin. 
"Collected after a 3-month interval. 
Dherte et al. 5 described one person who had Hb A, Hb P-Nilotic, and Hb S, and thus three 
active structural non-a genes. This is considered strong evidence in support of the hypoth-
esis that a recombination event during a crossover involving the a and ,B structural genes 
can produce a chromosome on which an "anti-Lepore" (/38) gene is present together with 
intact a and .B structural genes, i.e., a duplication chromosome. 6 
Lepore hemoglobins are known to occur in association with ,B-thalassemia. 3 The syn-
drome, which has been described in Greeks, Italians, and Yugoslavs (for a review see refs. 
3 and 8) and in New Guineans9 gives rise to a clinical condition that resembles homozy-
gous ,B-thalassemia. We have studied several members of a large family of Northern Sudan 
who were he terozygous for Hb P-Nilotic alone or in association with a ,8°-thalassemia. 
Unexpectedly, the patients with the Hb P-Nilotic-,8°-thalassemia condition had a moder-
ately severe thalassemia syndrome. Data from structural, hematological, and biosynthetic 
studies were consistent with the hypothesis that multiple recombination events resulted in 
the formation of the ,B?JP hybrid gene with an additional ,BA gene in cis to this gene, and of a 
modification of an untranscribed strand of DNA which has regulator function and which 
lies 5' to the .B" gene. Unlike other ,B genes, the ,BA gene in cis to the ,B?JP gene is repressed 
and almost not inducible when a ,B0-thalassemia determinant is present in trans. 
Materials and methods 
Blood samples. These were collected in ACD, mailed by air on ice. special delivery, to Augusta, 
Georgia, and arrived within 4 days. Informed consent was obtained from the donors according to the 
principles of the declaration of Helsinki prior to venepuncture. Occasionally the shipment included 
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HbA"" Hb F'Rl MCH-{3fiP MCH-f3A 
(%) (%) (pg/cell) (pg/cell) 
< 1.0 10.3 
< 1.0 
31.9 6.7 5.7 3.27 
69.l < 1.0 3.86 9.57 
63.5 < 1.0 5.09 9.72 




32.7 3.4 5.61 3.19 
33.1 3.1 6.16 3.54 
34.4 8.4 4.60 3.10 
34.2 8.2 4.99 3.30 
< 1.0 
72.34 < 1.0 3.98 11.5 
counter (Coulter Electronics, Inc., Hialeah , Fla. ). The clinical studies were done in Khartoum, Sudan , 
by standard methods. 10 
Hemoglobin analyses. (For references to methodology see ref. 11.) Electrophoretic examina-
tion of the hemoglobin was made by starch-gel electrophoresis at pH 9.0 and by citrate agar elec-
trophoresis at pH 6.1. The various hemoglobin components were quantitated by DEAE-cellulose 
chromatography with glycine-KCN-NaCI developers. The same method. but on a preparative scale, 
was used to isolate the variant in larger quantities from blood samples of the patient , her brother. her 
uncle, and her mother. Globin was prepared by the method of Anson and Mirsky, and the chains were 
separated by CM-cellulose chromatography. After aminoethylation with ethylenimine, about 200 mg 
of the non-a chain (referred to as {38" chain) was available for structural analyses . Part of this material 
was digested with trypsin, and the tryptic peptides were separated on a 0. 9 by 60 cm column of 
Chromobead resin, type P, at 50° C with pyridine-acetic acid volatile buffers. Isolated peptides were 
hydrolyzed with 6M HCl under reduced pressure at 110° C for 24 hr and occasionally for 72 hr. Amino 
acid analyses were made with a Spinco Model 121M automated amino acid analyzer equipped with 
high-sensitivity cuvettes and an integrator. The first 40 residues of th e chain were also put in se-
quence by means of a Beckman sequencer (Model 890C ; Beckman Instruments, Inc. , Palo Alto, 
Calif. ) equipped with an improved program (102974-576). PTH amino acid residues were analyzed 
after back hydrolysis with HI by means of the Spinco Model 121 M amino acid analyzer. 
Similar structural analyses were made on the f3A chain of Hb A isolated from the blood of the 
propositus (IV-2) with the Hb P-Nilotic-{3°-thalassemia condition. 
Biosynthetic analyses. Red cells from venous blood or bone marrow aspirate were washed 
three times with cold NKM solution (NaCl 8.18 gm/L ; KC! 0.37 gm/ L; MgCl2 · 6 11 20 1.42 gm/L) 
and were incubated in Dr. Abu-Sin's laboratory at Khartoum , Sudan , using the amino acid mixture 
with 14C-leucine as described elsewhere. 11 Aliquots were taken at different times as indicated later, 
washed with saline solution, and shipped by air to Augusta. Georgia. All red cell aliquots were lysed 
with equal volumes of water. and each of the resultin g whole cell lysates was divided into two samples 
for preparation of stroma-free hemolysate and whole cell globin, respectively. Stroma-frce hcmolysates 
were made by centrifuging whole cell lysates at 20,000 x g and 4° C for 30 min in a Sorval RC2 
centrifuge (Du Pont Instruments - Sorvall, Wilmington , Del. ). Hemoglobins in these hemolysates 
were isolated by chromatography on columns of DEAE-cellulose. 11 Aliquots ( 1 ml ) of effluent fractions 
of the columns were treated with perchloric acid and hydrogen peroxide for liquid scintillation count-
ing. Whole cell globins were made by precipitation of whole cell lysates with acid acetone. Globin was 
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Fig. I. Pedigree of the family with Hb P-Nilotic and /3-thalassemia. 
also made from isolated hemoglobin. These globins were analyzed by chromatography on CM-
cellulose with /3-mercaptoethanol-phosphate-urca buffers." 
Results 
Case and family report. Part of the pedigree of this large family is shown in Fig. 1. 
Patient H. A. R. (Case IV-2), an 18-year-old girl from Northern Sudan, was referred to one 
of us (A. A. S.) in June 1976 because of refractory anemia and splenomegaly which were 
thought to be present since early childhood. Close questionin g indicated no history of blood 
loss or febrile episodes, and her diet was described as adequate. She had never received a 
blood transfusion. Physical examination showed mild pallor and a spleen which was pal-
pable 6 cm below the left costal margin. 
Blood counts remained fairly constant over the period of May 1976 to June 1977. 
Representative hematological values, determined in June 1977, are given in Table I. The 
WBC count was 6.0 x 10"/L with a normal differential; the platelet count was 
148 x 10"/ L, and the rcticulocyte count was 6%. On a peripheral blood fi lm, marked 
anisopoikilocytosis. mild to moderate hypochromia, few nucleated red cells, and basophilic 
stippling were apparent. Bone manow examination showed normoblastic erythroid hy-
perplasia. The serum iron level was 69 µ,mol/L (385 µ, g/100 ml). Red cell survival studies 
with 5 1Cr as a label showed a t1h of 18 days (normal 28 to 30) with an increased uptake of 
the radioisotope by the spleen. 
The patient's brother (1\1. A. R., Case IV-I ), 26 years old, was not available for com-
plete investigation. Although he denied symptoms of anemia, he had consulted a surgeon 
on occasion because of dull pain and heaviness in the left hypochondrium. Physical 
examination revealed an enlarged spleen 4 cm below the left costal margin. He was 
anemic (Table I) although somewhat less severely than his sister. The WBC count was 
4.4 x l OH/L, with a normal differential and a normal platelet count. His blood film showed 
a moderate to marked poikilocytosis with mild hypochromia. An uncle (Case III-1 ) had 
similar hematological and clinical features. The mother (Case III-2), 50 years old, enjoyed 
good health and was without physical abnormality. The father (Case III-3), 55 years old, 
had diabetes mellitus but was otherwise normal. Hematological values for the parents arc 
included in Table I; the father and mother are first cousins (Fig. 1). 
Hemoglobin structure. When the hemoglobins from several members of this family 
were examined by electrophoresis and chromatography. a variant with properties some-
what similar to those of Hb S was observed in Cases Ill- L III-2, IV- I, and IV-2 (and three 
others ). The tryptic peptides of the abnormal non-a chain of this variant were isolated by 
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Fig. 2. Separation of globin chains on columns of CM-cellulose. Case III-2 had a Hb P-Nilotic trait 
with 28% Hb P, and Case IV-2 had the Hb P Nilotic-,8-thalassemia condition with 55% Hb P. It was 
not possible to obtain separation of the ,88 chain of Hb P-Nilotic and the ,BA chain of Hb A by this 
technique. although the presence of the ,88" chain could be appreciated when its level in the sample 
was high. 
which are identical in the normal f3 chain and 8 chain. had the correct composition 
(including the two valyl residues in T-4 and the three valyl residues in T-14 and T-14, 15). 
The compositions of T-2 and T-3 coincided with those of the normal f3 chain, whereas the 
compositions of the T-5, T-10. T-10, 11, T-12b, T-12c. and T-13 peptides agreed with th e 
corresponding peptides of the 8 chain. These data indicate that the sequence of residues 1 
to 22 is the sequence of the f3 chain and that of residues 50 to 146 is the sequence of the 8 
chain. This sequence corresponds to the described structure of the (38" chain of Hb 
P-Nilotic." The results of the automatic sequence determination of the first 40 residues 
corroborated these findings. All tryptic peptides of the f3 chain of the proposita's Hb A had 
the amino acid composition expec ted for corresponding fragments of the normal (3A chain 
(detailed results of these structural analyses will be provided upon request). 
Hemoglobin analyses. Hemoglobin composition and hematological data arc listed 
in Table I. The mother (Case III-2) appears to be a Hb P-Nilotic heterozygote, and the 
fath er (Case IIl-3) appears to be a (3°-thalassemia heterozygote (on the basis of the elevated 
level of Hb A2, the extremely low MCV and MCH values, and the biosynthetic data to be 
presented later). The two children (Cases IV-1 and IV-2) and the uncle (Case Jll-1) have 
the Hb P-Nilotic-(3°-thalassemia condition. The level of Hb A2 in these three patients was 
about 6% and that of Hb F was below 10%, the average values for Hb P-Nilotic and Hb A 
were 55'/C and 33%, respectively, and the MCV and MCH values were as low as seen in the 
father. The average amount of (38" chain per cell was 5. 4 ::t:: 0. 6 (S. D. ) pg ( n = 3), and th at 
of the (3A chain was 3.3 ::t:: 0.15 pg (n = 3). The level of Hb P-Nilotic in the mother and 
three distant relatives with the same Hb P-Nilotic heterozygosity averaged 28.0% ::t:: 1.9 
(n = 4), and that of Hb A2 was 2.85% ::t:: 0.25 (n = 4). The average amount of {38P chain 
per cell was 4.3 ::t:: 0.7 pg (n = 3), and that of th e (3\was 10.3 ::t:: 1.0 pg (n = 3). 
Biosynthetic analyses. Examples of chromatographic analyses of whole cell globin 
are given in Fig. 2. Since the separation of the {381' and (3A chains was only partial and 
always inadequate for separate calculations of the radioactivity in the respective chromato-
graphic zones. only the ratios of the a and the total non-a (/3A + {381') radioactivities are 
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Table II. Biosynthetic data on whole cell globin from peripheral blood of five 
members of the family with Hb P-Nilotic and ,B0-thalassemiaA 
Time of incubation a 
Subject Condition (min) Q'(Jj ) /3 + {3/'ill) /3 + {38"'-
III-2 A-P 30 6,948 5,224 1.33 
60 I0,456 6,440 1.62 
I20 26,116 I2,900 2.02 
III-3 A-{3-thal 30 7,I08 3,3I6 2.I4 
60 I3,088 6,568 1.99 
I20 I2,760 7,I84 1.78 
IV-I P-{3-thal 30 20,736 4,436 4.67 
60 7,2I6 2,180 3.3I 
I20 53,628 I3,636 3.84 
IV-2 P-{3-thal 30 8,252 2,600 3.I 7 
60 I9, 172 4,740 4.04 
120 29,432 7,420 3.97 
III-I P-{3-thal 30 7,784 1,836 4.24 
60 30,948 6,812 4.54 
120 21,348 5,688 3.75 
AThe amount of globin used in each analysis vaned from 20 to 40 mg. 
"Data are in cpm in the respective zones. Since the {3 and {38 chains did not separate, the total non-a chain 
activity is listed (see also Fig. 2). 
"Average value for Case 111-3 is 1.97 ± 0.18; average values for Cases IV-1, !V-2, and lll-1 are 4.0 ± 0.8 at 
30 min, 4.0 ± 0.6 at 60 min , and 3.9 ± 0.1at120 min. 
listed in Table II. The mother (Case 111-2) had an increasingly imbalanced synthesis at 0 
longer times of incubation. The father (Case Ill-3) had an average a/non-a total activity 
ratio of about 2.0, although a minimal decrease in the ratio was noted during prolonged 
incubation. The patients with Hb P-Nilotic-,B0-thalassemia (Cases IV-1 , IV-2, and III-1 ) 
had average ratios of 3.9, 3.7, and 4.2, respectively. 
The distribution of radioactivity in the Hb A and Hb P-Nilotic in peripheral blood is 
presented in Table III. The ratio of the total radioactivities incorporated into the Hb A and 
Hb P-Nilotic zones was 10 for Case III-2 with the Hb P-Nilotic trait but was only 2.1 and 
3.2 for Cases IV-2 and IIl-1 with the Hb P-Nilotic-,8°-thalassemia condition. A bone 
marrow sample obtained from Case III-1 and incubated for only 15 min gave a Hb A/Hb 
P-Nilotic ratio of only 1.66. However, further analyses of the isolated Hb A fraction by 
CM-cellulose chromatography showed the presence of as much as 25% radioactivity du e to 
an unidentified nonhemoglobin protein. Such a component was not identified in the Hb 
P-Nilotic fraction. The corrected value for the Hb A/Hb P-Nilotic ratio in bone marrow is 
therefore about 1.2. Analyses of the isolated hemoglobins from this bone marrow sample 
gave an a/non-a value of 0.2 for Hb P-Nilotic and 1.5 for Hb A. In peripheral blood, the 
values were 2.1 to 2.9 for Hb P-Nilotic and 0.8 to 1.0 for Hb A. This indicates that the 
production of ,BfV chains was more effective in bone marrow than in peripheral blood. In 
fact, the specific activities of the ,aar chain and the ,BA chains which were separated from 
Hb P and Hb A having been isolated from peripheral blood samples gave a ,aar;,aA ratio of 
0.15 for one of the Hb P heterozygotes and an average ratio of 0. 22 for two cases with Hb 
P-,8°-thalassemia. The corresponding value in the bone marrow aspirate of the Hb P-
,80-thalassemia patient was 0.49. These data make it most unlikely th~t the relative pro-
portions of Hb P and Hb A in the two types of conditions were altered after translation as is 
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Table III. Biosynthetic data on the hemoglobin components isolated from blood 
and bone marrow samples of three members of the family with Hb 
P-Nilotic trait or with Hb P-Nilotic-{3°-thalassemiaA 
Time of incubation 
Case Condition Material (min) 
IIl-2 A-P Blood 30 
60 
120 
IV-2 P- J3-thal Blood 30 
60 
120 
III-1 P-/3-thal Blood 60 
120 
Bone marrow 15 
AThe amount of hemoglobin chromatographed varied from 25 to 40 mg. 
"Total cpm in the respective zones. 
cseparated by DEAE-cellulose chromatography. 
Total activityB 




















"Average value for Case IIl-2 is 10.0 ± 0.4 and 2.6 ± 0.6 for Cases IV-2 and III-I (peripheral blood only). 
"Corrected for presence of contaminant protein (see text). 
Discussion 
The hemoglobin variant. The abnormal hemoglobin in the proposita and other 
members of this family was identified as Hb P-Nilotic, 3 an anti-Lepore hemoglobin which, 
like Hb Miyada4 and others, has a f3 chain sequence near the amino-terminus and a 8 chain 
sequence near the carboxy-terminus. These abnormal hemoglobins are produced by hy-
brid genes which probably arise by abnormal recombination between homologous f3 and 8 
genes due to base mispairing during meiosis. 6 A similar mechanism may also result in the 
Lepore type of abnormal hemoglobins which have a 8 chain sequence near the amino-
terminus and a f3 chain sequence near the carboxy-terminus. However, the anti-Lepore 
type of abnormality cannot be considered as a "reverse Lepore" because a functioning f3A 
gene is present in cis to the {38 hybrid gene. 5 The mutation which is characteristic for Hb 
P-Nilotic can also be found in Hb Lincoln Park which, in addition, has a deletion of a valyl 
residue in position 137 of the 13ar chain. 13 Structural analyses have shown that this second 
abnormality is absent in the {38 chain of the Hb P present in our family. Hb Lincoln Park is 
a stable hemoglobin variant with normal functional properties, has been found in several 
members of a Mexican family, and comprises about 14% of total circulating hemoglobin in 
heterozygotes. 13 The proportion of Hb P-Nilotic in the he terozygotes of the Sudanese 
family described here averaged 28% (Table I). 
The mother with Hb P-Nilotic trait. Hb Lepore heterozygotes phcnotypically 
resemble 8,8-thalassemia heterozygotes. 3 However, anti-Lepore heterozygotes such as the 
mother (Case III-2) of the present family did not have any hematological abnormality. The 
absence of a hemolytic syndrome in this person is consistent with normal erythropoiesis, 
and a balanced synthesis of hemoglobin chains would be expected. Nonetheless, progres-
sive imbalance of chain synthesis was observed as the in vitro incubation of reticulocytes 
proceeded. Perhaps this may be explained by an early decline of the in vitro synthesis of 
.ear chains. Comparison of the in vitro synthesis data for bone marrow and peripheral blood 
su ggests that the ,88 chains of Hb P-Nilotic are synthesized to a much larger extent in 
nucleated erythroid precursors than in peripheral blood reticulocytes (see also Roberts et 
al., 14 who studied the {38 chain of Hb Miyada). 
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The father with {1°-thalassemia trait. Hematological observations and data from in 
vitro synthesis experiments indicate that the father (Case III-3) has a (3°-thalassemia trait; 
the a/non-a ratio (total radioactivity) of 1.97 :±:: 0.18 (S.D. ) (n = 3) is similar to that ob-
served for a group of patients with a (3°or1>(3°-thalassemia trait with complete absence of (3" 
chain production in cis ( 1.96 :±:: 0.30; n = 9) and rather different from the ratio in 13+_ 
thalassemia heterozygotes (1.23 ±0.05; n = 6). These control data were determined in 
heterozygotes of families in which Hb S and (3-thalassemia genes were segregating or in 
parents of homozygous thalassemia patients without any (3A chain production ( unpub-
lished observation). 
The members with Hb P-Nilotic-{1°-thalassemia. The separate he terozygosities 
in the mother (Case llI-2) and the father (Case Ill-3) define the condition in the patients 
IV-1 and IV-2 (and also in III-1 ) as Hb P-Nilotic-(3°-thalassemia. The most interesting 
feature of this condition is the low content of Hb A. The small amounts of (3A chains 
(MCH-(3A = 3.3 :±:: 0.2 ( S.D. ) pg/cell) are produced only by the (3 gene in cis to the (3o P 
hybrid gene. Data from chemical analyses leave little doubt that these are normal (3A 
chains. The Hb A/Hb P-Nilotie total activity ratio (2.6 :±:: 0.6; Table III) is about one fourth 
of the value observed in the Hb P-Nilotic heterozygote (10 :±:: 0.4). This difference is in 
close agreement with that which is observed between the ratios of the absolute amounts of 
(3A and (3oP chains in peripheral red blood cells (Hb P- (3°-thalassemia cases: 0.6 :±:: 0.05; 
Hb P heterozygotes: 2.4 :±:: 0. 5). Moreover, the in vitro synthesis imbalance is more severe 
than in either parent. 
Genetic considerations. Mutant or normal (3 genes in trans to a (3°-thalassemia 
determinant usually compensate in part for the deficit of (3 chain synthesis. For instance, 
patients with the Hb S-(3°-thalassemia condition have a mean corpuscular (35 chain con- n 
tent (MCH-(38 ) of about 9 pg/cell which is 50% higher than the 6 pg/cell of the Hb S 
heterozygote (ref. 12 and unpublished data). The two members of this family with hetero-
zygous (3°-thalassemia averaged 9.5 pg of (3A chain per cell, which is similar to the values of 
MCH-(35 in patients with Hb S- (3°-thalassemia and less than the average 11 pg of (3 chains 
(/3A + 13s) per cell in patients with Hb S- (3+-thalassemia. Thus a normal or variant (3 gene 
in trans to a (3°-thalassemia determinant will produce as much as 9 pg of (3 chains per cell; 
however, the (3A gene which is in cis to the (3oP gene and in trans to the (3°-thalassemia 
cieterminant in the three patients with the Hb P-Nilotic- (3°-thalassemia condition pro-
duces only one third of this amount. It should also be noted that the content of (31>" chains 
in these patients (5.4 :±:: 0.6 (S.D.) pg; n = 5) is only slightly higher than that in the Hb 
P-Nilotic heterozygotes ( 4.3 :±:: 0. 7 pg; n = 3); this differe nce is not significant ( t = 1.87, 
d.f. = 4). Presumably, the (31>" gene is maximally active or nearly so whether a normal or a 
(3°-thalassemia chromosome is in trans to it because of the deficiency of the (3A gene in cis 
to the (3op hybrid gene. 
These considerations offer an explanation for the dependence of the clinical and 
hematological expression of the (3"-thalassemia determinant in this family on the type of 
chromosome that is present in trans to the thalassemia. Only a mild anemia exists in the 
(3°-thalassemia heterozygote with a normal a locus and a normal (3 locus in trans , but when 
the o-(38P-(3Acomplex is present in trans (P-Nilotic- (3°-thalassemia), the clinical manifes-
tations are more severe. and the in vitro synthesis imbalance is markedly increased at all 
incubation times. Indeed. the normal (3A gene in cis to the (3or gene must be repressed. 
Unlike other (3 genes this (3 ·' gene is not derepressed to any great extent in a condition 
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Fig. 3. Repeated crossing-over during meiosis as a possible mechanism for the development of the 
non-a chain in Hb Lincoln Park and Hb P-Nilotic. The sections Y, Z, and W are considered to be 
untranscribed strands of DNA between structural genes which have regulatory functions. For further 
details see text. (Modified from Honig GR, Shamsuddin M, Mason G, and Vida LN: Proc Sec Natl 
Acad Sci USA 75:1475, 1978.) 
The mechanism proposed to account for these observations is similar to that described 
to explain the structural characteristics of the {38 chain of Hb Lincoln Park. 13 The top 
section of Fig. 3 illustrates the occurrence of an unequal crossover between the f3 and 8 
genes resulting in the formation of a {38 hybrid gene and of two additional crossovers 
causing the deletion of the codon for valyl residue in position 137. Fig. 3 is a modification of 
Fig. 4 of ref. 13; the modification concerns the intergenic strands of DNA, designated Y, Z 
and W, which may have regulatory functions." A single crossover between f3 and 8 genes, 
as suggested by Badr et al., 6 is clearly inadequate to explain our findings in the three 
patients with Hb P Nilotic-{3°-thalassemia because the duplicated Z strand would induce 
f3A gene activity in cis to the {38" gene which is contrary to what has been observed. More 
than one additional crossover may occur, 16 as is suggested in the lower part of Fig. 3. The 
additional postulated crossovers or other, ill-defined events occurred between untrans-
cribed DNA sequences, Z and W in Fig. 3, resulting in a modified Z' segment. One 
chromosome resulting from these recombinations carries a 8 chain gene and a duplex of 
non-a genes, one of which is a {38P hybrid gene and the second a {3A gene that is now under 
repression by a mutated operator strand of DNA 5' to it (segment Z'). Data from investiga-
tions on the structures of the mRNAs and restriction mapping of DNA will be the subject 
of a future report. 
We are indebted to Dr. W. A. Schroeder for helpful discussion and to Dr. George Honig for a 
preprint of his article describing the discovery of Hb Lincoln Park. A. A. S. thanks Dr. W. Page Faulk 
of the Department of Immunology, Medical University of South Carolina, Charleston, S. C .. for advice 
and encouragement. 
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